SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ovarian cancer (OC) and HER2-positive metastatic colorectal cancer (mCRC), along with the confirmatory study design of the phase...
BEIJING, Sept. 28, 2025 /PRNewswire/ -- A news report from China.org.cn on the technological application in Xinjiang's agriculture:  New Agricultural...
SINGAPORE and LONDON, Sept. 29, 2025 /PRNewswire/ -- Thunes , the Smart Superhighway to move money around the world, is transforming the cross-border payment...
TOKYO, Sept. 29, 2025 /PRNewswire/ -- Nippon Express (Belgium) N.V./S.A. (hereinafter "NX Belgium"), a group company of NIPPON EXPRESS HOLDINGS, Inc., will participate in...
BANDAR SERI BEGAWAN, Brunei, Sept. 29, 2025 /PRNewswire/ -- Over 2,000 residents across all age groups converged at BIBD Connects, Taman Mahkota Jubli Emas,...